GAM
ENTA icon

Gotham Asset Management’s Enanta Pharmaceuticals ENTA Stock Holding History

Gotham Asset Management’s Portfolio ENTA Stock Details ENTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-13,990
Closed -$720K – 1097
2020
Q1 		$720K Sell
13,990
-15,489
-53% -$826K 0.02% 638
2019
Q4 		$1.82M Sell
29,479
-11,091
-27% -$688K 0.03% 490
2019
Q3 		$2.44M Buy
40,570
+8,225
+25% +$611K 0.04% 420
2019
Q2 		$2.73M Buy
32,345
+13,693
+73% +$1.23M 0.04% 436
2019
Q1 		$1.78M Sell
18,652
-3,830
-17% -$344K 0.03% 516
2018
Q4 		$1.59M Sell
22,482
-7,752
-26% -$594K 0.02% 547
2018
Q3 		$2.58M Buy
30,234
+15,062
+99% +$1.51M 0.04% 457
2018
Q2 		$1.76M Sell
15,172
-77
-0.5% -$7.68K 0.03% 495
2018
Q1 		$1.23M Buy
15,249
+3,973
+35% +$306K 0.02% 579
2017
Q4 		$662K Sell
11,276
-836
-7% -$41.9K 0.01% 664
2017
Q3 		$567K Sell
12,112
-7,156
-37% -$288K 0.01% 680
2017
Q2 		$693K Sell
19,268
-19,313
-50% -$618K 0.01% 692
2017
Q1 		$1.19M Sell
38,581
-12,048
-24% -$375K 0.02% 637
2016
Q4 		$1.7M Sell
50,629
-17,885
-26% -$513K 0.02% 533
2016
Q3 		$1.82M Sell
68,514
-42,722
-38% -$992K 0.02% 511
2016
Q2 		$2.45M Buy
111,236
+22,605
+26% +$592K 0.03% 499
2016
Q1 		$2.6M Buy
+88,631
New +$2.47M 0.03% 540
2015
Q4 		– Sell
-311,850
Closed -$11.3M – 897
2015
Q3 		$11.3M Buy
311,850
+197,318
+172% +$8.47M 0.11% 274
2015
Q2 		$5.15M Buy
114,532
+66,661
+139% +$2.59M 0.04% 445
2015
Q1 		$1.47M Buy
47,871
+36,504
+321% +$1.42M 0.01% 551
2014
Q4 		$578K Sell
11,367
-40,863
-78% -$1.83M ﹤0.01% 711
2014
Q3 		$2.07M Buy
+52,230
New +$2.08M 0.02% 528

Other funds holding ENTA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Gotham Asset Management's ENTA Position: Q2 2020 in Review

Gotham Asset Management sold out of Enanta Pharmaceuticals (ENTA) in Q2 2020, closing a stake of 13,990 shares — an estimated $720K sold.

Gotham Asset Management first reported a position in ENTA in Q3 2014 and held it in 22 quarters. The position peaked at $11.3M in Q3 2015. 180 funds tracked by Wall St. Rank hold ENTA as of Q2 2020.

  • Gotham Asset Management reported no remaining Enanta Pharmaceuticals position as of Q2 2020 after selling out during the quarter.
  • Gotham Asset Management sold 13,990 Enanta Pharmaceuticals shares in Q2 2020, an estimated $720K.
  • Gotham Asset Management first reported a position in Enanta Pharmaceuticals in Q3 2014 and held it in 22 quarters.
  • Gotham Asset Management's Enanta Pharmaceuticals position peaked at $11.3M in Q3 2015.
  • 180 funds tracked by Wall St. Rank held Enanta Pharmaceuticals as of Q2 2020.

Based on Gotham Asset Management's 13F filing for Q2 2020, filed 13 Aug 2020.